Motivators and Barriers to Exercise in Parkinson's Disease

Mitra Afshari*, Amy Yang, Danny Bega

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Abstract

Background: Despite evidence for the benefits of exercise in Parkinson's disease (PD), many patients remain sedentary for undefined reasons. Objective: To compare exercise habits, perceptions about exercise, and barriers to exercise in 'low' (<3 h/week) and 'high' (=3 h/week) exercisers with PD. Methods: A 48-item survey was administered to PD patients at an outpatient academic center. Chi-squared tests were used to compare the percentage differences between low-and high-exercisers with two-sided tests and a significant level of 0.05. Results: 243 surveys were collected over three months; 28 were excluded due to incomplete data, leaving 215 to be analyzed. 49.3% reported 'low'-exercise and 50.7% reported 'high'-exercise. High-exercisers participated in higher intensity exercise regimens (83.4% versus 32.1%, p = 0.001). High-exercisers were more likely to start exercising after being diagnosed (54.2% versus 27.8%, p < 0.001), whereas low-exercisers were more likely to reduce their amount of exercise (40.2% versus 15.9%, p < 0.001). Low-exercisers required more motivating factors. Both groups benefited from having a significant other or a personal trainer motivate them, and both were more likely to exercise if their neurologist encouraged them. Low-exercisers reported twice as many barriers as high-exercisers (p = 0.001). Barriers that were significantly more common in low-exercisers were: lacking someone to motivate them (33.3% versus 10.5%, p < 0.001), fatigue (20.8% versus 15.2%, p = 0.005), and depression (16.7% versus 7.6%, p = 0.045). Conclusions: There are significant differences between people with PD who exercise regularly and those who do not in terms of motivators and barriers. These findings should be considered when tailoring recommendations for PD patients to encourage exercise, and in designing future interventions.

Original languageEnglish (US)
Pages (from-to)703-711
Number of pages9
JournalJournal of Parkinson's disease
Volume7
Issue number4
DOIs
StatePublished - 2017

Funding

Dr. Afshari and Amy Yang have nothing to disclose. Dr. Bega has served as a consultant for Teva Pharmaceuticals and Cynapsus Therapeutics, Inc. He serves on the speaker’s bureau for Acadia Pharmaceuticals, Inc. He has received grant support from the National Parkinson Foundation.

Keywords

  • Adult
  • Parkinson's disease
  • exercise
  • falls
  • physical activity
  • quality of life

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Motivators and Barriers to Exercise in Parkinson's Disease'. Together they form a unique fingerprint.

Cite this